Artivion | CRY - Loan Capital

Stock Price
38.33
Daily Change
0.33 0.87%
Monthly
-13.50%
Yearly
35.63%
Q1 Forecast
37.14

Artivion reported $214.87M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Abbott USD 9.9B 1.7B Dec/2025
Accuray USD 127.32M 3.53M Sep/2025
AngioDynamics USD 5.9M 5.9M Feb/2025
Artivion USD 214.87M 669K Sep/2025
AtriCure USD 61.86M 0 Dec/2025
Baxter International USD 9.47B 726M Dec/2025
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Boston Scientific USD 10.99B 12M Sep/2025
Edwards Lifesciences USD 598.2M 200K Sep/2025
Inogen USD 0 0 Jun/2022
Integra LifeSciences USD 1.79B 565.41M Sep/2025
J&J USD 39.44B 30M Dec/2025
Mesa Laboratories USD 104.2M 104.3M Sep/2024
Orthofix International USD 157.22M 172K Sep/2025
Pfizer USD 57.41B 93M Sep/2025
ResMed USD 403.92M 4.74M Dec/2025
Stryker USD 14.86B 14M Dec/2025
Surmodics USD 29.55M 30K Sep/2024
Tandem Diabetes Care USD 310.04M 446K Dec/2025
Teleflex USD 2.57B 769.86M Sep/2025
Terumo JPY 99.9B 12M Dec/2025
Trinity Biotech USD 114.86M 4.81M Sep/2025